CF
RUBY

Centaurus Financial’s Rubius Therapeutics, Inc RUBY Stock Holding History

Centaurus Financial’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-12,500
Closed -$224K – 993
2021
Q3 		$224K Sell
12,500
-1,500
-11% -$32.6K 0.02% 621
2021
Q2 		$342K Hold
14,000
– – 0.03% 532
2021
Q1 		$371K Sell
14,000
-1,500
-10% -$21.9K 0.04% 444
2020
Q4 		$118K Buy
+15,500
New +$92.1K 0.01% 705

Other funds holding RUBY

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Centaurus Financial's RUBY Position: Q4 2021 in Review

Centaurus Financial sold out of Rubius Therapeutics, Inc (RUBY) in Q4 2021, closing a stake of 12,500 shares — an estimated $224K sold.

Centaurus Financial first reported a position in RUBY in Q4 2020 and held it in 4 quarters. The position peaked at $371K in Q1 2021. 108 funds tracked by Wall St. Rank hold RUBY as of Q4 2021.

  • Centaurus Financial reported no remaining Rubius Therapeutics, Inc position as of Q4 2021 after selling out during the quarter.
  • Centaurus Financial sold 12,500 Rubius Therapeutics, Inc shares in Q4 2021, an estimated $224K.
  • Centaurus Financial first reported a position in Rubius Therapeutics, Inc in Q4 2020 and held it in 4 quarters.
  • Centaurus Financial's Rubius Therapeutics, Inc position peaked at $371K in Q1 2021.
  • 108 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q4 2021.

Based on Centaurus Financial's 13F filing for Q4 2021, filed 1 Feb 2022.